Primary cutaneous marginal zone B-cell lymphoma: Response to treatment and disease-free survival in a series of 137 patients

Journal of the American Academy of Dermatology

Volumn 69, Issue 3, 2013, Pages 357-365

  Servitje, Octavio ^a   Muniesa, Cristina ^b   Benavente, Yolanda ^c   Monsálvez, Verónica ^d   Garcia Muret, M Pilar ^e   Gallardo, Fernando ^f   Domingo Domenech, Eva ^c   Lucas, Anna ^c   Climent, Fina ^a   Rodriguez Peralto, Jose L ^d   Ortiz Romero, Pablo L ^d   Sandoval, Juan ^c   Pujol, Ramon M ^f   Estrach, M Teresa ^g  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL DE VILADECANS   (Spain)

^c HOSPITAL DURAN I REYNALS   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f HOSPITAL DEL MAR   (Spain)

^g INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

B cell lymphoma; disease free survival; extracutaneous disease; primary cutaneous marginal zone B cell lymphoma; skin relapses; treatment

Indexed keywords

ARTICLE; B CELL LYMPHOMA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; DISEASE FREE SURVIVAL; EXCISION; FOLLOW UP; MARGINAL ZONE LYMPHOMA; OVERALL SURVIVAL; PRIMARY CUTANEOUS MARGINAL ZONE B CELL LYMPHOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SKIN LYMPHOMA; TREATMENT RESPONSE;

B-CELL LYMPHOMA; COMPLETE REMISSION; CR; DFS; DISEASE-FREE SURVIVAL; EORTC; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER; EXTRACUTANEOUS DISEASE; INTERNATIONAL SOCIETY FOR CUTANEOUS LYMPHOMAS; INTRAVENOUS; ISCL; IV; PARTIAL REMISSION; PCMZBCL; PR; PRIMARY CUTANEOUS MARGINAL ZONE B-CELL LYMPHOMA; SKIN RELAPSES; TREATMENT; WHO; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84882865710     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.04.047     Document Type: Article

References (29)

1. R. Willemze, E.S. Jaffe, G. Burg, L. Cerroni, E. Berti, and S.H. Swerdlow WHO-EORTC classification for cutaneous lymphomas Blood 105 2005 3768 3785
2. S.H. Swerlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, and H. Stein WHO classification of tumors of hematopoietic and lymphoid tissues 2008 IARC Lyon
3. N.J. Senff, E.M. Noordijk, Y.H. Kim, M. Bagot, E. Berti, L. Cerroni European Organization for Research and Treatment of Cancer; International Society for Cutaneous Lymphoma European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas Blood 112 2008 1600 1609
4. Y.H. Kim, R. Willemze, N. Pimpinelli, S. Whittaker, E.A. Olsen, A. Ranki ISCL and the EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC) Blood 110 2007 479 484
5. E. Olsen, S. Whittaker, Y. Kim, M. Duvic, H.M. Prince, and S.R. Lessin Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the cutaneous lymphoma task force of the European Organization for Research and Treatment of Cancer J Clin Oncol 29 2011 2598 2607
6. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 157 181
7. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother 34 1966 163 170
8. K. Grønbaek, P.H. Møller, T. Nedergaard, K. Thomsen, O. Baadsgaard, and K. Hou Jensen Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases Br J Dermatol 142 2000 913 923
9. B. Yang, R.R. Tubbs, W. Finn, A. Carlson, J. Pettay, and E.D. Hsi Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization Am J Surg Pathol 24 2000 694 702
10. O. Servitje, F. Gallardo, T. Estrach, R.M. Pujol, A. Blanco, and A. Fernández-Sevilla Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases Br J Dermatol 147 2002 1147 1158
11. E. Bathelier, L. Thomas, B. Balme, B. Coiffier, F. Berger, and M. Ffrench Marginal zone B-cell lymphoma affecting the skin: histological and phenotypic study of 49 cases Ann Dermatol Venereol 135 2008 748 752
12. E.M. Bessell, C.E. Humber, S. O'Connor, J.S. English, W. Perkins, and P.D. Dickinson Primary cutaneous B-cell lymphoma in Nottinghamshire UK: prognosis of subtypes defined in the WHO-EORTC classification Br J Dermatol 167 2012 1118 1123
13. O. Servitje, R.M. Martí, T. Estrach, J. Palou, F. Gallardo, and A. Limón Occurrence of Hodgkin's disease and cutaneous B-cell lymphoma in the same patient: a report of two cases Eur J Dermatol 10 2000 43 46
14. K. Oka, R. Nagayama, N. Yonekawa, T. Nihei, N. Sando, and Y. Yatabe Concurrent gastric MALT and Hodgkin lymphoma: a case report Int J Surg Pathol 20 2012 201 204
15. A. Zettl, T. Rüdiger, A. Marx, H.K. Müller-Hermelink, and G. Ott Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases Histopathology 46 2005 217 228
16. P. Gerami, S.C. Wickless, S. Rosen, T.M. Kuzel, A. Ciurea, and J. Havey Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma J Am Acad Dermatol 59 2008 245 254
17. R.F. de Misa, and M. Megido Autoimmune hemolytic anemia and cutaneous T-cell lymphoma: review of the literature Acta Haematol 89 1993 168
18. J.P. Knox, M.C. Massa, R. Gradini, T.S. Fu, P. Stiff, and S.E. Welykyj Autoimmune hemolytic anemia in a patient with mycosis fungoides Cutis 45 1990 52 56
19. D. Velázquez, P. de Pablo, D. García, and J.R. Ramírez Primary cutaneous marginal zone B-cell lymphoma: an atypical case Dermatol Online J 16 2010 5
20. J.J. Hoefnagel, M.H. Vermeer, P.M. Jansen, F. Heule, P.C. van Voorst Vader, and C.J. Sanders Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases Arch Dermatol 141 2005 1139 1145
21. N.J. Senff, J.J. Hoefnagel, P.M. Jansen, M.H. Vermeer, J. van Baarlen, and W.A. Blokx Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers J Clin Oncol 25 2007 1581 1587
22. H. Takino, C. Li, S. Hu, T.T. Kuo, E. Geissinger, and H.K. Muller-Hermelink Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States Mod Pathol 21 2008 1517 1526
23. P. Golling, A. Cozzio, R. Dummer, L. French, and W. Kempf Primary cutaneous B-cell lymphomas-clinicopathological, prognostic and therapeutic characterization of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome Leuk Lymphoma 49 2008 1094 1103
24. P.L. Zinzani, P. Quaglino, N. Pimpinelli, E. Berti, G. Baliva, S. Rupoli Italian Study Group for Cutaneous Lymphomas Prognostic factors in primary cutaneous B cell lymphoma: the Italian study group for cutaneous lymphomas J Clin Oncol 24 2006 1376 1382
25. N.J. Senff, and R. Willemze The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch cutaneous lymphoma group Br J Dermatol 157 2007 1205 1211
26. N.J. Senff, J.J. Hoefnagel, K.J. Neelis, M.H. Vermeer, E.M. Noordijk, R. Willemze Dutch Cutaneous Lymphoma Group Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification Arch Dermatol 143 2007 1520 1526
27. Y. Peñate, B. Hernández-Machín, L.I. Pérez-Méndez, F. Santiago, B. Rosales, and O. Servitje Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicenter study; the Spanish Working Group on Cutaneous Lymphoma Br J Dermatol 167 2012 174 179
28. A. Salar, E. Domingo-Domenech, C. Estany, M.A. Canales, F. Gallardo, and O. Servitje Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-Associated lymphoid tissue type Cancer 115 2009 5210 5217
29. P. Gerami, S.C. Wickless, C. Querfeld, S.T. Rosen, T.M. Kuzel, and J. Guitart Cutaneous involvement with marginal zone lymphoma J Am Acad Dermatol 63 2010 142 145